healthcms.jpg

Featured image by Monster Ztudio/Shutterstock

Leveraged Loans

Ensemble RCM lines up $4.4B syndicated loan backing recap, dividend to PE sponsors

US syndicated loans backing dividend recaps totaled a record $74 billion in 2025.

Ensemble RCM plans to use a roughly $4.4 billion seven-year term loan B to refinance its existing facility and fund a shareholder dividend, according to sources. Commitments to the JPMorgan-led deal are due by 5 p.m. ET on Tuesday, Jan. 27.

S&P Global Ratings affirmed the corporate and facility ratings at B, with a stable outlook, and there’s a recovery rating of 3 on the loan. “Although credit metrics will temporarily weaken in the immediate term, we believe Ensemble’s organic growth will facilitate deleveraging,” the agency said.

The company is also upsizing its revolver to $350 million.

The borrower’s existing covenant-lite TLB due August 2029 (S+300, 0% floor) was issued in a January 2024 refinancing. Ensemble returned to market in June 2024 and May 2025 with add-ons of $814 million and $800 million, respectively, in both cases to fund dividends. There is currently $3.27 billion of the TLB outstanding. Goldman Sachs is the administrative agent.

Ensemble Health Partners, based in Blue Ash, Ohio, provides technology-enabled revenue cycle management services to hospitals and health systems. The company is backed by Golden Gate Capital, Berkshire Partners, and Warburg Pincus. Bon Secours Mercy Health (BSMH) is also a shareholder.

Featured image by Monster Ztudio/Shutterstock

Learn about our editorial standards.